Defence Therapeutics Inc. (DTC) — Defensive Interval Ratio

Latest as of December 2025: 74 days

Defence Therapeutics Inc. (DTC) has a Defensive Interval Ratio of 74 days as of December 2025. Defensive assets of €222.68K (cash €-, short-term investments €-, receivables €222.68K) cover 74 days of daily cash needs of €3.03K/day. Check DTC intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

74 days
Days of operational coverage

Defensive Assets

€222.68K
Cash + ST Investments + Receivables

Daily Cash Need

€3.03K
Current Liabilities ÷ 365

Current Liabilities

€1.11 Million
EUR

Defence Therapeutics Inc. Defensive Interval Ratio (2021–2024)

This chart shows how Defence Therapeutics Inc.'s Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of December 2025, the ratio stands at 74 days, meaning defensive assets of €222.68K can fund 74 days of operations without new revenue. Also explore net asset growth rate of Defence Therapeutics Inc. to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Defence Therapeutics Inc. (2021–2024)

The table below presents the year-by-year Defensive Interval Ratio for Defence Therapeutics Inc. from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see DTC market cap.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2024 9 days €96.52K €11.11K/day €- €- ▼ -239 days
2023 248 days €149.60K €604.04/day €- €- ▲ +239 days
2022 9 days €27.76K €3.03K/day €- €- ▼ -205 days
2021 214 days €71.62K €334.95/day €- €-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)